首页> 外文期刊>Clinical drug investigation >Prevention of Propofol-Induced Injection Pain by Sufentanil A Placebo-Controlled Comparison with Remifentanil
【24h】

Prevention of Propofol-Induced Injection Pain by Sufentanil A Placebo-Controlled Comparison with Remifentanil

机译:舒芬太尼预防由异丙酚引起的注射痛-与瑞芬太尼进行的安慰剂对照比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objective: Propofol produces anaesthesia with rapid recovery but also causes pain or discomfort on injection. The effect of remifentanil in prevention of propofol-induced injection pain has been demonstrated in earlier studies. However, sufentanil, an opioid analgesic, has not been evaluated as an agent for managing pain on injection of propofol. In this study we aimed to compare the efficacy of remifentanil and sufentanil for the prevention of propofol-induced pain.Methods: This double-blind, placebo-controlled clinical study was carried out from July 2006 to February 2007, and included patients who were candidates for elective surgery in a university hospital. From 92 American Society of Anesthesiologists (ASA) status I-II adult patients, 80 were randomly assigned to four groups of 20 each. Patients received 2 mL of sufentanil 0.01 mg, 2mL of remifentanil 0.01 mg, 2 mL of remifentanil 0.02 mg, or 2 mL of saline 60 seconds prior to administration of 5 mL of propofol 1 %. Patients were asked prior to losing consciousness whether they felt any pain due to propofol injection, and their pain scores were evaluated on the four-point scale of Ambesh et al.Results: The incidence of pain was significantly lower in the remifentanil 0.02-mg group, remifentanil 0.01-mg group and sufentanil group compared with the saline group (40%, 70%, 75% and 100%, respectively, p < 0.05). Median pain intensity scores were significantly lower in the group receiving remifentanil 0.02 mg than in the sufentanil group (0 and 1 respectively, p < 0.05). The median intensity of propofol-induced pain was statistically similar between the groups receiving sufentanil or remifentanil 0.01 mg and the placebo group (1,1 and 1, respectively, p > 0.05).Conclusion: Remifentanil 0.02 mg administered over 60 seconds before propofol administration is more effective than sufentanil 0.01 mg, remifentanil 0.01 mg or placebo administered 1 minute prior to propofol in reducing the incidence and intensity of injection pain.
机译:背景与目的:异丙酚可快速恢复麻醉效果,但注射时也会引起疼痛或不适。早期研究已证明瑞芬太尼可预防丙泊酚引起的注射痛。然而,阿片类镇痛药舒芬太尼尚未被评估为用于注射丙泊酚时减轻疼痛的药物。在这项研究中,我们旨在比较瑞芬太尼和舒芬太尼在预防异丙酚引起的疼痛中的功效。方法:这项双盲,安慰剂对照的临床研究于2006年7月至2007年2月进行,纳入了候选患者在大学医院进行选择性手术。从92位美国麻醉医师协会(ASA)的I-II位成人患者中,将80位患者随机分为四组,每组20名。在服用5%异丙酚1%之前60秒钟,患者接受2 mL舒芬太尼0.01 mg,2 mL瑞芬太尼0.01 mg,2 mL瑞芬太尼0.02 mg或2 mL盐水。在失去知觉之前询问患者是否因注射异丙酚而感到疼痛,并以Ambesh等人的四分制评估他们的疼痛评分。结果:瑞芬太尼0.02 mg组的疼痛发生率显着降低,瑞芬太尼0.01 mg组和舒芬太尼组与生理盐水组相比(分别为40%,70%,75%和100%,p <0.05)。接受瑞芬太尼0.02 mg的组中位疼痛强度评分显着低于舒芬太尼组(分别为0和1,p <0.05)。接受舒芬太尼或瑞芬太尼0.01 mg的组与安慰剂组之间的丙泊酚引起的疼痛中位强度在统计学上相似(分别为1,1和1,p> 0.05)。结论:在异丙酚给药前60秒内,给予瑞芬太尼0.02 mg与舒芬太尼0.01毫克,瑞芬太尼0.01毫克或丙泊酚之前1分钟服用安慰剂相比,在减少注射疼痛的发生率和强度方面更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号